• Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
investor investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor

€0.0

Valuation: €0.0

round
investor investor investor investor investor investor investor

€0.0

Valuation: €0.0

round
*

$20.0m

Valuation: $1.5b

Series D
Total Funding000k
More about Biofourmis
Made with AI
Edit

Biofourmis is a digital health company that leverages advanced technology to provide hospital-level care in the comfort of patients' homes. The company serves healthcare providers, pharmaceutical companies, and patients by offering a predictive health platform that uses biosensors and deep learning algorithms to monitor and analyze patient data. Operating in the healthcare technology market, Biofourmis' business model revolves around selling its platform and services to hospitals and healthcare systems, as well as partnering with pharmaceutical companies to enhance drug efficacy and patient outcomes. The company generates revenue through subscription fees, service contracts, and partnerships. By focusing on predictive analytics and personalized care, Biofourmis aims to prevent costly medical events and improve patient outcomes.

Keywords: predictive analytics, digital health, biosensors, deep learning, hospital-at-home, personalized care, healthcare technology, remote monitoring, patient outcomes, pharmaceutical partnerships.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Biofourmis

Edit
Biovotion
ACQUISITION by Biofourmis Nov 2019
Gaido Health
ACQUISITION by Biofourmis Apr 2020
Copilot IQ
ACQUISITION by Biofourmis Oct 2024